Literature DB >> 1752451

Neurochemistry of hepatic encephalopathy.

C O Record1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1752451      PMCID： PMC1379148          DOI： 10.1136/gut.32.11.1261

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  46 in total

1.  Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.

Authors:  J STAHL
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

2.  Metabolism and toxicity of ammonia.

Authors:  W V McDERMOTT
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

3.  The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability.

Authors:  W D Lo; S R Ennis; G W Goldstein; D L McNeely; A L Betz
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

4.  Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy.

Authors:  B T Hourani; E M Hamlin; T B Reynolds
Journal:  Arch Intern Med       Date:  1971-06

5.  Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure.

Authors:  C Yurdaydin; H Hörtnagl; P Steindl; C Zimmermann; C Pifl; E A Singer; E Roth; P Ferenci
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

6.  Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.

Authors:  C Zimmermann; P Ferenci; C Pifl; C Yurdaydin; J Ebner; H Lassmann; E Roth; H Hörtnagl
Journal:  Hepatology       Date:  1989-04       Impact factor: 17.425

7.  Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy.

Authors:  R F Butterworth; J Lavoie; J F Giguère; G P Layrargues; M Bergeron
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

8.  Effect of methionine loading and endogenous hypermethioninaemia on blood mercaptans in man.

Authors:  H Al Mardini; J Leonard; K Bartlett; S Lloyd; C O Record
Journal:  Clin Chim Acta       Date:  1988-08-15       Impact factor: 3.786

9.  Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.

Authors:  G M Knudsen; H E Poulsen; O B Paulson
Journal:  J Hepatol       Date:  1988-04       Impact factor: 25.083

10.  Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; T A Reader; G P Layrargues; R F Butterworth
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996
View more
  13 in total

1.  Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Authors:  Hanan Al Mardini; Andrew Douglass; Christopher Record
Journal:  Metab Brain Dis       Date:  2006-05-04       Impact factor: 3.584

Review 2.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

4.  Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency.

Authors:  C H Dejong; N E Deutz; P B Soeters
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  Ammonia modifies enteric neuromuscular transmission through glial γ-aminobutyric acid signaling.

Authors:  David E Fried; Ralph E Watson; Simon C Robson; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-24       Impact factor: 4.052

6.  End-stage Liver Disease in Children.

Authors:  Robert H. Squires
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

7.  Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial.

Authors:  C J Rees; K Oppong; H Al Mardini; M Hudson; C O Record
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 8.  Liver cirrhosis.

Authors:  E J Williams; J P Iredale
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

9.  Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.

Authors:  S Sarhan; B Knödgen; C Grauffel; N Seiler
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

10.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.